Cyclical pamidronate infusions in postmenopausal osteoporosis
- 1 August 1996
- Vol. 25 (1) , 69-75
- https://doi.org/10.1016/0378-5122(96)01118-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Use of Clodronate in Disorders of Calcium and Skeletal Metabolism1Published by S. Karger AG ,2015
- Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosisBone, 1996
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: Dose-response relationship and influence of tumour typeAnnals of Oncology, 1994
- Cyclic etidronate: Has the rose lost its bloom?The American Journal of Medicine, 1993
- Alternatives to HRT in prevention and treatmentBailliere's Clinical Rheumatology, 1993
- Effects of one-year cyclical treatment with clodronate on postmenopausal bone lossBone, 1993
- Oral tiludronate: Pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosisBone, 1992
- Intermittent Cyclical Etidronate Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990